CD163 and type 2 diabetes mellitus: No differences were found in serum sTWEAK levels between study groups, but serum sCD163 levels, sCD163/sTWEAK index, C-reactive protein (CRP) and HOMA-IR were increased in patients with type 2 diabetes in 11.0%, 15.0%, 33.3% and 77.7% respectively, after adjusting for WHR and systolic blood pressure.